Literature DB >> 427766

Augmentation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells by depletion of glass-adherent cells prior to in vitro activation.

M B Mokyr, D P Braun, S Dray.   

Abstract

Entities:  

Mesh:

Year:  1979        PMID: 427766

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  Deficiency in immunocompetence of mice cured from large MOPC-315 plasmacytomas by melphalan therapy.

Authors:  S Shoval; R Ophir; S Ben-Efraim
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Melphalan-mediated potentiation of antitumor immune responsiveness of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor.

Authors:  R C Bocian; S Ben-Efraim; S Dray; M B Mokyr
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  Suppression of antitumor immunity by macrophages in spleens of mice bearing a large MOPC-315 tumor.

Authors:  Q W Ye; M B Mokyr; J M Pyle; S Dray
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

4.  Effect of low-dose cyclophosphamide therapy on specific and nonspecific T cell-dependent immune responses of spleen cells from mice bearing large MOPC-315 plasmacytomas.

Authors:  J A Wise; M B Mokyr; S Dray
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Augmentation of host antitumor immunity by low doses of cyclophosphamide and mafosfamide in two animal tumor models.

Authors:  T Reissmann; R Voegeli; J Pohl; P Hilgard
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Suppressor cells in the effector phase of autologous cytotoxic reactions in cancer patients.

Authors:  M Eura; T Maehara; T Ikawa; T Ishikawa
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 7.  Cyclophosphamide and melphalan as immunopotentiating agents in cancer therapy.

Authors:  S Dray; M B Mokyr
Journal:  Med Oncol Tumor Pharmacother       Date:  1989
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.